Literature DB >> 23172690

Redo of percutaneous renal denervation in a patient with recurrent resistant hypertension after primary treatment success.

T Lambert1, A Nahler, F Leisch.   

Abstract

A 79-year-old patient was treated with percutaneous renal denervation (RDN) due to resistant arterial hypertension in the summer of 2010. After primary treatment success with a decrease of blood pressure from 170/100 to 130/80 mm Hg 6 months postablation, the blood pressure rose again at 12 months despite maintenance of the pharmacologic regimen and the decision was made to perform a second RDN procedure. Three months following the second RDN procedure, blood pressure was lowered to 130/77 mm Hg.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23172690     DOI: 10.1002/ccd.24753

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  3 in total

1.  Endovascular renal denervation: a novel sympatholytic with relevance to chronic kidney disease.

Authors:  Neil A Hoye; James C Baldi; Tracey L Putt; John B Schollum; Gerard T Wilkins; Robert J Walker
Journal:  Clin Kidney J       Date:  2013-11-08

2.  Redo renal denervation using a multi-electrode radiofrequency system in patients with persistent therapy-resistant hypertension.

Authors:  J Daemen; L Feyz; L Van Zandvoort; N M Van Mieghem
Journal:  Neth Heart J       Date:  2017-06       Impact factor: 2.380

3.  Effects of Renal Denervation on Renal Artery Function in Humans: Preliminary Study.

Authors:  Adelina Doltra; Arthur Hartmann; Philipp Stawowy; Leonid Goubergrits; Titus Kuehne; Ernst Wellnhofer; Rolf Gebker; Christopher Schneeweis; Bernhard Schnackenburg; Murray Esler; Eckart Fleck; Sebastian Kelle
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.